Connect with us

Cannabis News

India-Based HEMPCORP Is Plotting Its Path Of Success In The CBD Industry

Published

on

India-Based-HEMPCORP-is-Plotting-Its-Path-of-Success-in-the-CBD-Industry

By using cannabinoids and terpenes from hemp, HEMPCORP plans to provide organic medicine to global consumers in an effort to carve out a green future. Based in Uttarakhand, India, where hemp is legal, the company is set to fulfill the global demand for medicinal CBD, CBG, and other non-psychoactive cannabinoids.

Market projections predict that by 2024, the market size could grow by over 900% of the current one with the US market hitting over $20 billion. HEMPCORP plans to be a comprehensive global CBD products supplier in partnership with FMCG distributors.

Why CBD?

One of the 100+ cannabinoids in the cannabis plant, CBD has proven to be beneficial in the treatment of various ailments, including cancer-related symptoms, with relatively no side effects in comparison to synthetic drugs.

HEMPCORP plans to utilize greenhouses and modular growth capsules to facilitate the production of a wide range of plant species with definitive efficiency assured by the use of artificial intelligence in tissue cultures.

About HEMPCORP

HEMPCORP specializes in medical cannabinoid cultivation, processing, and refinement, with production expected to be in full swing in a year. The management team comprises of industry experts and entrepreneurs.

Pouline Ireri lives in Kenya and is new at TOC but plans to contribute much more in the near future. She graduated from the University of Nairobi and is a Business consultant/Micro Finance specialist. Her affinity for cannabis and CBD came naturally through her own use and become an advocate based on the positive effects and results she experienced.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com

Copyright © 2020 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.